Cite
MLA Citation
A. Reiter et al.. “P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY.” HemaSphere, vol. 6, n.d., pp. 905–906. http://access.bl.uk/ark:/81055/vdc_100158013878.0x000017